Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search
  1. NCI-F Publications

Search
  1. Year Published:

Your search returned 12 results.
User Information
Export Records
  1. 1.   Safety and feasibility of anti-CD19 CAR T cells with fully human binding domains in patients with B-cell lymphoma
  2. Brudno, Jennifer N; Lam, Norris; Vanasse, Danielle; Shen, Yueh-Wei; Rose, Jeremy J; Rossi, John; Xue, Allen; Bot, Adrian; Scholler, Nathalie; Mikkilineni, Lekha; Roschewski, Mark; Dean, Robert; Cachau,Raul; Youkharibache, Philippe; Patel, Rashmika; Hansen, Brenna; Stroncek, David F; Rosenberg, Steven A; Gress, Ronald E; Kochenderfer, James N
  3. Nature medicine. 2020, Jan 20;
  1. 2.   Th17 Cells Are Long Lived and Retain a Stem Cell-like Molecular Signature
  2. Muranski, P.; Borman, Z. A.; Kerkar, S. P.; Klebanoff, C. A.; Ji, Y.; Sanchez-Perez, L.; Sukumar, M.; Reger, R. N.; Yu, Z. Y.; Kern, S. J.; Roychoudhuri, R.; Ferreyra, G. A.; Shen, W.; Durum, S. K.; Feigenbaum, L.; Palmer, D. C.; Antony, P. A.; Chan, C. C.; Laurence, A.; Danner, R. L.; Gattinoni, L.; Restifol, N. P.
  3. Immunity. 2011, Dec; 35(6): 972-985.
  1. 3.   Immunotherapy reaches new milestones in cancer eradication
  2. Kotlan, B.; Umansky, V.; Malyguine, A. M.; Marincola, F. M.; Shurin, M. R.
  3. Immunotherapy. 2011, Oct; 3(10): 1131-1137.
  1. 4.   Transduction of SIV-Specific TCR Genes into Rhesus Macaque CD8(+) T Cells Conveys the Ability to Suppress SIV Replication
  2. Barsov, E. V.; Trivett, M. T.; Minang, J. T.; Sun, H. S.; Ohlen, C.; Ott, D. E.
  3. Plos One. 2011, Aug; 6(8): 9.
  1. 5.   Immunity to Murine Prostatic Tumors: Continuous Provision of T-Cell Help Prevents CD8 T-Cell Tolerance and Activates Tumor-Infiltrating Dendritic Cells
  2. Shafer-Weaver, K. A.; Watkins, S. K.; Anderson, M. J.; Draper, L. J.; Malyguine, A.; Alvord, W. G.; Greenberg, N. M.; Hurwitz, A. A.
  3. Cancer Research. 2009 69(15): 6256-6264.
  1. 6.   Melanoma Progression Despite Infiltration by In Vivo-primed TRP-2-specific T Cells
  2. Singh, V.; Ji, Q. Y.; Feigenbaum, L.; Leighty, R. M.; Hurwitz, A. A.
  3. Journal of Immunotherapy. 2009 32(2): 129-139.
  1. 7.   Novel Human Interleukin-15 Agonists
  2. Zhu, X. Y.; Marcus, W. D.; Xu, W. X.; Lee, H. I.; Han, K. P.; Egan, J. O.; Yovandich, J. L.; Rhode, P. R.; Wong, H. C.
  3. Journal of Immunology. 2009 183(6): 3598-3607.
  1. 8.   Sensitizing tumor cells to immune-mediated cytotoxicity
  2. Shanker, A.; Sayers, T.
  3. Immune-Mediated Diseases: From Theory to Therapy. 2007; 601 : 163-171.
  1. 9.   Autologous lymphoma vaccines induce human T cell responses against multiple, unique epitopes
  2. Baskar, S.; Kobrin, C. B.; Kwak, L. W.
  3. Journal of Clinical Investigation. 2004 113(10): 1498-1510.
  1. 10.   Adoptive cellular therapy with tumor vaccine draining lymph node lymphocytes after vaccination with HLA-B7/beta(2)- microglobulin gene-modified autologous tumor cells
  2. Meijer, S. L.; Dols, A.; Urba, W. J.; Hu, H. M.; Smith, J. W.; Vetto, J.; Wood, W.; Doran, T.; Chu, Y.; Sayaharuban, P.; Alvord, W. G.; Fox, B. A.
  3. Journal of Immunotherapy. 2002 25(4): 359-372.
  1. 11.   Redirecting migration of T cells to chemokine secreted from tumors by genetic modification with CXCR2
  2. Kershaw, M. H.; Wang, G.; Westwood, J. A.; Pachynski, R. K.; Tiffany, H. L.; Marincola, F. M.; Wang, E.; Young, H. A.; Murphy, P. M.; Hwu, P.
  3. Human Gene Therapy. 2002 13(16): 1971-1980.
  1. 12.   Thymidine Kinase (Tk) Gene-Transduced Human Lymphocytes Can Be Highly Purified, Remain Fully Functional, and Are Killed Efficiently With Ganciclovir
  2. Munshi, N. C.; Govindarajan, R.; Drake, R.; Ding, L. M.; Iyer, R.; Saylors, R.; Kornbluth, J.; Marcus, S.; Chiang, Y.; Ennist, D.; Kwak, L.; Reynolds, C.; Tricot, G.; Barlogie, B.
  3. Blood. 1997 89(4): 1334-1340.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel